Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

23.03.2026

1 Acta Neuropathol
13 Alzheimers Dement
1 Am J Geriatr Psychiatry
3 Ann Neurol
1 Biochemistry (Mosc)
1 BMJ
1 Brain
1 Brain Res
1 Exp Gerontol
4 Exp Neurol
1 Int J Neurosci
13 J Alzheimers Dis
2 J Am Geriatr Soc
2 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
1 JAMA
1 Nat Med
1 Nat Rev Neurol
3 Neurobiol Dis
1 Neurosci Lett
1 PLoS One
2 Proc Natl Acad Sci U S A


    Acta Neuropathol

  1. SALEEM T, Mobius W, Schmitz M, da Silva Correia A, et al
    A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease.
    Acta Neuropathol. 2026;151:27.
    >> Share


    Alzheimers Dement

  2. DESVARIEUX M, Rundek T, Ahsan H, Narvaez J, et al
    Accelerating real-world prediction and research in Alzheimer's: The M3AD study.
    Alzheimers Dement. 2026;22:e71174.
    >> Share

  3. BAX F, Oltmer J, Auger CA, Bonkhoff A, et al
    APOE-mediated sex differences in microvascular pathology and AD-associated proteinopathies in the medial temporal lobe.
    Alzheimers Dement. 2026;22:e71206.
    >> Share

  4. ZHANG Y, Li Y, Wang Q, Pang J, et al
    Late-life methionine restriction attenuates neuroinflammation in Alzheimer's disease mice via FGF21 activation in a metabolism-independent manner.
    Alzheimers Dement. 2026;22:e71287.
    >> Share

  5. SUN J, Zufiria-Gerboles B, Passaretti M, Volpe G, et al
    Tracking early cognitive decline in preclinical AD with brain MRI similarity.
    Alzheimers Dement. 2026;22:e71170.
    >> Share

  6. KUNDU P, Zhu C, Huentelman M, Deoni SCL, et al
    Brain volume trajectories in young children are associated with polygenic scores for late-onset Alzheimer's disease risk.
    Alzheimers Dement. 2026;22:e71279.
    >> Share

  7. INTRONA A
    ARIAs are not random: A posterior and border-zone vascular vulnerability model.
    Alzheimers Dement. 2026;22:e71304.
    >> Share

  8. RAE RJ, Alberhasky JMH, Baillet M, Bangasser DA, et al
    Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71291.
    >> Share

  9. PIOTROWSKI SL, Allnutt MA, Johnson K, Tanaka T, et al
    Herpesvirus genome integration in whole-genome sequences of dementia and control cohorts.
    Alzheimers Dement. 2026;22:e71047.
    >> Share

  10. PERRY KE, Merenstein J
    From cradle to cortex: An exposome- and equity-centered perspective of neurocognitive aging and dementia risk in the era of climate change.
    Alzheimers Dement. 2026;22:e71158.
    >> Share

  11. FU W, Chao X, Wang Y, Liu S, et al
    Bile acids are associated with baseline and longitudinal amyloid and tau pathology in patients with Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71307.
    >> Share

  12. ZAMANI J, Vahid A, Wilson EN, Hosseini SMH, et al
    Multivariate patterns of plasma biomarkers predict region-specific Alzheimer's pathology and cognitive decline across independent cohorts.
    Alzheimers Dement. 2026;22:e71265.
    >> Share

  13. PEDERSEN TJ, Clemens SG, Winer JR, Sharma A, et al
    Wake-promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance.
    Alzheimers Dement. 2026;22:e71298.
    >> Share

  14. GUTSTEIN DB, Iorga M, Stocks J, Gill N, et al
    Identifying neuropathologic disease in primary progressive aphasia using narrative speech.
    Alzheimers Dement. 2026;22:e71294.
    >> Share


    Am J Geriatr Psychiatry

  15. RAJKUMAR G, Uthayakumar H, Khoury MA, Valcic M, et al
    Genetic and Hormonal Contributions to Psychosis Symptoms in Alzheimer's Disease: A Sex-Stratified Analysis.
    Am J Geriatr Psychiatry. 2026 Feb 24:S1064-7481(26)00067.
    >> Share


    Ann Neurol

  16. BROWN CA, Cousins KAQ, Korecka M, McGrew E, et al
    Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers.
    Ann Neurol. 2026 Mar 15. doi: 10.1002/ana.78194.
    >> Share

  17. XU YR, Tao Y, Lish AM, Li S, et al
    Novel Monoclonal Antibody Detects Small Abeta Oligomers More Sensitively Than Lecanemab in Alzheimer's Disease CSF, Serum and Culture Media.
    Ann Neurol. 2026 Mar 16. doi: 10.1002/ana.78196.
    >> Share

  18. TROPEA TF, Stevenson PA, Flitter M, Meehan D, et al
    Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease.
    Ann Neurol. 2026 Mar 18. doi: 10.1002/ana.78201.
    >> Share


    Biochemistry (Mosc)

  19. ZAGRYADSKAYA YA, Nesterov SV, Mitkevich VA, Kozin SA, et al
    Beta-Amyloid Suppresses Mitochondrial ATP Production in Human Neuroblastoma Cells.
    Biochemistry (Mosc). 2026;91:230-244.
    >> Share


    BMJ

  20. IACOBUCCI G
    Alzheimer's drugs: Lecanemab and donanemab to be reconsidered for NHS after appeal.
    BMJ. 2026;392:s551.
    >> Share


    Brain

  21. WEISE CM, Abu-Rumeileh S, Otto M
    From 'senile dementia' to non-vascular Alzheimer's synucleinopathy: the evolution of dementia classification.
    Brain. 2026 Mar 16:awag103. doi: 10.1093.
    >> Share


    Brain Res

  22. MIAO Z, Yang Z, Huang Q, Fan J, et al
    Ding-zhi-xiao-wan attenuates Alzheimer's disease pathology and cognitive deficits in mouse model.
    Brain Res. 2026;1881:150263.
    >> Share


    Exp Gerontol

  23. ZAMMIT AR, Gross AL, Yu L, Barnes LL, et al
    Harmonization of late-life participation in cognitively stimulating activities across four cohort studies of cognitive aging.
    Exp Gerontol. 2026;216:113069.
    >> Share


    Exp Neurol

  24. LI W, Chen S, Liu Z, Lei B, et al
    Differential effects and underlying mechanisms of voluntary, forced, and combined exercise on ameliorating Alzheimer's disease pathophenotypes.
    Exp Neurol. 2026;401:115731.
    >> Share

  25. ZHU X, Lai X, Deng J, Long Y, et al
    Naturally occurring antibodies against ASC reduced in Alzheimer's disease and alleviating AD-type pathology in APP/PS1 mouse.
    Exp Neurol. 2026 Mar 15:115728. doi: 10.1016/j.expneurol.2026.115728.
    >> Share

  26. ZHAO Y, Chen W, Zhou F
    IL-1beta neutralization ameliorates cognitive deficits and tau pathology in a mouse model of Alzheimer's disease with hyperhomocysteinemia.
    Exp Neurol. 2026;401:115729.
    >> Share

  27. CHEN W, Huang N, Huang W, Wang M, et al
    TREM2 as a possible link between Alzheimer's disease and diabetes mellitus.
    Exp Neurol. 2026 Mar 18:115739. doi: 10.1016/j.expneurol.2026.115739.
    >> Share


    Int J Neurosci

  28. RS R, G S G, S S, P A, et al
    Self-Improved LeNet and Modified SegNet for Alzheimer's Disease Classification using MRI.
    Int J Neurosci. 2026 Mar 14:1-24. doi: 10.1080/00207454.2026.2644529.
    >> Share


    J Alzheimers Dis

  29. YUAN M, Zhou HY
    CTAD 2025: Key trends redefining therapeutic and diagnostic strategies in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 15:13872877261430764. doi: 10.1177/13872877261430764.
    >> Share

  30. JIANG X, Lv G, Xiong X, Yuan J, et al
    Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2026 Mar 16:13872877261430376. doi: 10.1177/13872877261430376.
    >> Share

  31. HU S, Ge J, Wang G, Zhao M, et al
    Plasma biomarker changes following deep cervical lymphatic venous anastomosis: An exploratory study in Alzheimer's disease using single-molecule array technology.
    J Alzheimers Dis. 2026 Mar 16:13872877261431355. doi: 10.1177/13872877261431355.
    >> Share

  32. KIM MG, Woo SH, Kim GW, Choi HK, et al
    Efficacy and safety of Woohwangchungsimwon in combination with donepezil for behavioral and psychological symptoms of dementia in probable Alzheimer's disease: An assessor-blinded randomized controlled trial.
    J Alzheimers Dis. 2026 Mar 16:13872877261431692. doi: 10.1177/13872877261431692.
    >> Share

  33. GAO P, Chen B, Xu D, Wang Q, et al
    Differential effects of PSEN1 mutations (p.P117L with ataxia and p.P264L without ataxia) in early-onset Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 16:13872877261430771. doi: 10.1177/13872877261430771.
    >> Share

  34. CHEN YJ, Gaba A, Yang HW, Maher M, et al
    Associations between polygenic risk scores for Alzheimer's disease and postoperative delirium risk.
    J Alzheimers Dis. 2026 Mar 16:13872877261430955. doi: 10.1177/13872877261430955.
    >> Share

  35. MA J, Zhou S, Zhu W, Tao Y, et al
    Periodontitis associated with multi-region brain functional alterations and cognitive impairment: A cross-sectional study in normal cognition, amnestic mild cognitive impairment, and Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 16:13872877261426906. doi: 10.1177/13872877261426906.
    >> Share

  36. CANET G, Lucey BP, Blessing EM, Planel E, et al
    Lifelong heat exposure as a potential contributor to Alzheimer's disease resilience.
    J Alzheimers Dis. 2026 Mar 18:13872877261433226. doi: 10.1177/13872877261433226.
    >> Share

  37. PANDEY JP, Namboodiri AM, Nietert PJ
    Immunoglobulin allotypes and RELN alleles and humoral immunity to HSV1 in patients with Alzheimer's disease and matched controls.
    J Alzheimers Dis. 2026 Mar 18:13872877261431862. doi: 10.1177/13872877261431862.
    >> Share

  38. MESSAOUDI SA, Alsaleh A, AlSalem LA, Rameshbabu S, et al
    Association of genetic variants in cyclin-dependent kinase 5 with Alzheimer's disease in a Saudi cohort.
    J Alzheimers Dis. 2026 Mar 18:13872877261427358. doi: 10.1177/13872877261427358.
    >> Share

  39. ZHU W, Li H, Wang K, Sun M, et al
    Evidence integration of acupuncture for prevention and treatment of Alzheimer's disease and mild cognitive impairment from a neuroimaging perspective.
    J Alzheimers Dis. 2026 Mar 20:13872877261420235. doi: 10.1177/13872877261420235.
    >> Share

  40. JIAN JM, Li XP, Xie JH, Hu JN, et al
    Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer's disease pathology.
    J Alzheimers Dis. 2026 Mar 20:13872877261431844. doi: 10.1177/13872877261431844.
    >> Share

  41. DAMODARASAMY M, Hernandez GJ, Johnson RS, Keene CD, et al
    Lecanemab alters basement membrane collagen IV in viable microvessels isolated from brains with high Alzheimer's disease neuropathology.
    J Alzheimers Dis. 2026 Mar 20:13872877261433167. doi: 10.1177/13872877261433167.
    >> Share


    J Am Geriatr Soc

  42. MILLER-WINDER AP, Relerford RR, Schierer A, Murawski A, et al
    Phenotypes of Older Adults Planning for Alzheimer's Disease Support.
    J Am Geriatr Soc. 2026 Mar 20. doi: 10.1111/jgs.70401.
    >> Share

  43. REUBEN DB, Chambliss AB, Katz BJ, Lopez AS, et al
    Rational Use of Blood-Based Biomarkers for Alzheimer's Disease: Navigating Between the Hope and the Hype.
    J Am Geriatr Soc. 2026 Mar 19. doi: 10.1111/jgs.70384.
    >> Share


    J Neural Transm (Vienna)

  44. HESAROOEYEH ZG, Khalili E, Michel TM, Vafaee MS, et al
    The pathogenic role of gut microbiota dysbiosis in Alzheimer's disease: a narrative review of neuroimaging evidence.
    J Neural Transm (Vienna). 2026 Mar 14. doi: 10.1007/s00702-026-03126.
    >> Share

  45. LEAVITT VM, Simani L, Haghighi AB, Koch M, et al
    Language dysfunction as a primary feature of cognitive decline in neurological populations.
    J Neural Transm (Vienna). 2026;133:397-407.
    >> Share


    J Neurol Neurosurg Psychiatry

  46. PEROVNIK M, Simoncic U, Jamsek J, Gregoric Kramberger M, et al
    Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages.
    J Neurol Neurosurg Psychiatry. 2026;97:316-324.
    >> Share


    JAMA

  47. RUBIN R
    Lithium for Alzheimer Disease-Pilot Study Sets the Stage for Larger Trials.
    JAMA. 2026 Mar 20. doi: 10.1001/jama.2026.3046.
    >> Share


    Nat Med


  48. A biomarker of Alzheimer's disease could be a useful diagnostic tool for other amyloidoses.
    Nat Med. 2026 Mar 19. doi: 10.1038/s41591-026-04336.
    >> Share


    Nat Rev Neurol

  49. DUZEL E, Kreutz MR
    Maintaining and regaining episodic memory in Alzheimer disease: a circuit-based perspective.
    Nat Rev Neurol. 2026 Mar 16. doi: 10.1038/s41582-026-01189.
    >> Share


    Neurobiol Dis

  50. HUANG J, Rehman H, Doan C, Stein TD, et al
    Corrigendum to 'Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease' Neurobiology of Disease 219 (2026) Article Number 107257.
    Neurobiol Dis. 2026 Mar 16:107348. doi: 10.1016/j.nbd.2026.107348.
    >> Share

  51. GIUFFRE GM, Scalese A, Quaranta D, Donnarumma F, et al
    The impact of insulin resistance on cognitive impairment and cerebrospinal fluid biomarkers in Alzheimer's disease.
    Neurobiol Dis. 2026;222:107352.
    >> Share

  52. CHENG B, Cheng S, Wei W, Pan C, et al
    Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study.
    Neurobiol Dis. 2026 Feb 25:107334. doi: 10.1016/j.nbd.2026.107334.
    >> Share


    Neurosci Lett

  53. WANG C, Li J, Liu Q, Yang R, et al
    Retraction notice to "Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-kappaB activation in a rat model of amyloid-beta-induced Alzheimer's disease" [Neurosci. Lett. 491 (2011) 127-132].
    Neurosci Lett. 2026 Mar 12:138574. doi: 10.1016/j.neulet.2026.138574.
    >> Share


    PLoS One

  54. SIAM MBH, Khan MR, Elahe MF, Arman MS, et al
    Effects of similarity networks in graph-based multi-omics classification.
    PLoS One. 2026;21:e0344754.
    >> Share


    Proc Natl Acad Sci U S A


  55. Correction for Chen et al., RNA-binding activity of PHGDH drives amyloid-beta production in a human brain organoid model of sporadic Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2606894123.
    >> Share

  56. FISCHER CM, Edu IA, Sneideris T, Baronaite I, et al
    Reversibility and beta-sheet formation are decoupled in tau condensate aging.
    Proc Natl Acad Sci U S A. 2026;123:e2522993123.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016